Inhibition of rat liver UDP-glucuronosyltransferase by silymarin and the metabolite silibinin-glucuronide

被引:51
作者
D'Andrea, V [1 ]
Pérez, LM [1 ]
Pozzi, EJS [1 ]
机构
[1] Univ Nacl Rosario, CONICET, Inst Fisiol Expt, Fac Ciencias Bioquim & Farmaceut, Rosario, Argentina
关键词
silymarin; bilirubin; UGT; silibinin-glucuronide; human hepatic microsomes;
D O I
10.1016/j.lfs.2005.01.011
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 [基础医学];
摘要
The inhibitory effects of silymarin, its main constituent silibinin and the metabolite silibinin-glucuronide on UDP-glucuronosiltransferase (UGT) were evaluated in rat hepatic microsomes. Three substrates were chosen to cover both UGT1A and UGT2B family isozymes: bilirubin (substrate of UGT1A1), p-nitrophenol (UGT1A6) and ethinylestradiol (UGT2B1 and 2B3 for position C17 and UGT1A1 for position 0). The study of p-nitrophenol and bilirubin glucuronidation indicated that silymarin (SM) and silibinin glucuronide (SB-G) were enzyme inhibitors. The kinetic analysis showed that the type of inhibition was competitive in all cases and the Ki obtained were: for p-nitrophenol glucuronidation, Ki(SB-G)(app): 14 +/- 1 mu g/ml and Ki(SM)(app): 51 +/- 10 mu g/ml and for bilirubin glucuronidation, K SB-G: 16 3 tg/ml. In tum, ethinylestradiol glucuronidation was not affected by any of the compounds studied suggesting that the inhibitory effect was restricted to UGT1A isozymes. Similar studies performed using human hepatic microsomes showed that SM and SB-G were also inhibitors of human UGT1A isozymes. In conclusion, administration of silymarin or its main constituent silibinin could lead to the decrease in the glucuronidation of substrates whose conjugation depends on UGT1A isozymes in a process mediated by silibinin-glucuronide, though their effect in humans needs further investigation. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:683 / 692
页数:10
相关论文
共 27 条
[1]
INHIBITION OF RAT-LIVER CYTOSOLIC GLUTATHIONE-S-TRANSFERASE BY SILYBIN [J].
BARTHOLOMAEUS, AR ;
BOLTON, R ;
AHOKAS, JT .
XENOBIOTICA, 1994, 24 (01) :17-24
[2]
THE UDP GLUCURONOSYLTRANSFERASE GENE SUPERFAMILY - SUGGESTED NOMENCLATURE BASED ON EVOLUTIONARY DIVERGENCE [J].
BURCHELL, B ;
NEBERT, DW ;
NELSON, DR ;
BOCK, KW ;
IYANAGI, T ;
JANSEN, PLM ;
LANCET, D ;
MULDER, GJ ;
CHOWDHURY, JR ;
SIEST, G ;
TEPHLY, TR ;
MACKENZIE, PI .
DNA AND CELL BIOLOGY, 1991, 10 (07) :487-494
[3]
Chrungoo V J, 1997, Indian J Exp Biol, V35, P256
[4]
Preventive effect of silymarin against taurolithocholate-induced cholestasis in the rat [J].
Crocenzi, FA ;
Pozzi, EJS ;
Pellegrino, JM ;
Garay, EAR ;
Mottino, AD ;
Roma, MG .
BIOCHEMICAL PHARMACOLOGY, 2003, 66 (02) :355-364
[5]
Beneficial effects of silymarin on estrogen-induced cholestasis in the rat:: A study in vivo and in isolated hepatocyte couplets [J].
Crocenzi, FA ;
Pozzi, EJS ;
Pellegrino, JM ;
Favre, CO ;
Garay, EAR ;
Mottino, AD ;
Coleman, R ;
Roma, MG .
HEPATOLOGY, 2001, 34 (02) :329-339
[6]
EBNER T, 1993, MOL PHARMACOL, V43, P649
[7]
Milk thistle (Silybum marianum) for the therapy of liver disease [J].
Flora, K ;
Hahn, M ;
Rosen, H ;
Benner, K .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 1998, 93 (02) :139-143
[8]
Kren V, 2000, DRUG METAB DISPOS, V28, P1513
[9]
Analysis of the active components of silymarin [J].
Kvasnicka, F ;
Bíba, B ;
Sevcík, R ;
Voldrich, M ;
Krátká, J .
JOURNAL OF CHROMATOGRAPHY A, 2003, 990 (1-2) :239-245
[10]
MECHANISM FOR THE PROTECTIVE EFFECTS OF SILYMARIN AGAINST CARBON TETRACHLORIDE-INDUCED LIPID-PEROXIDATION AND HEPATOTOXICITY IN MICE - EVIDENCE THAT SILYMARIN ACTS BOTH AS AN INHIBITOR OF METABOLIC-ACTIVATION AND AS A CHAIN-BREAKING ANTIOXIDANT [J].
LETTERON, P ;
LABBE, G ;
DEGOTT, C ;
BERSON, A ;
FROMENTY, B ;
DELAFORGE, M ;
LARREY, D ;
PESSAYRE, D .
BIOCHEMICAL PHARMACOLOGY, 1990, 39 (12) :2027-2034